Scienture (NASDAQ:SCNX) Posts Earnings Results, Beats Expectations By $0.02 EPS

Scienture (NASDAQ:SCNX) announced its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.02, FiscalAI reports. The company had revenue of $0.34 million during the quarter, compared to analyst estimates of $1.96 million.

Scienture Stock Up 3.3%

NASDAQ:SCNX traded up $0.01 during mid-day trading on Thursday, hitting $0.47. 1,153,556 shares of the company’s stock were exchanged, compared to its average volume of 1,939,076. Scienture has a fifty-two week low of $0.24 and a fifty-two week high of $2.60. The company has a 50 day simple moving average of $0.38 and a 200-day simple moving average of $0.40.

Hedge Funds Weigh In On Scienture

An institutional investor recently bought a new stake in Scienture stock. Virtu Financial LLC acquired a new stake in Scienture Holdings, Inc. (NASDAQ:SCNX) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned 0.22% of Scienture as of its most recent SEC filing. Institutional investors own 5.68% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Scienture in a report on Wednesday, June 24th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Scienture presently has an average rating of “Hold” and an average price target of $1.50.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.